There is plenty to not like about CASM. What about the operating loss? How about the leverage? The lawsuit? Lack of cash?

The biggest problem is Foresight. An injunction will stop this product cold. Legal fees can kill the company. If not, then surely damages will drain the coffers.

Other than Foresight, CASM sells commodity patient monitors. Have you heard of MindRay? They're Chinese and are determined to take over the market. How can a $30 mln company compete with a $ bln company that has access to Chinese engineering and manufacturing? It's hopeless without Foresight.

But it's like being at Foxwoods and you're down to your last few red chips. You cannot lose much more at this point.